Business Description
Rhoen Klinikum AG
ISIN : DE0007042301
Share Class Description:
LTS:0NQH: Ordinary SharesTotal Employee Number:
19,184Compare
Compare
Traded in other countries / regions
RHK.Germany0NQH.UKRHK.AustriaRHKJF.USA IPO Date
2009-10-12Description
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.73 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | 1.02 | |||||
Interest Coverage | 12.2 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.51 | |||||
Beneish M-Score | -2.39 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.6 | |||||
3-Year EBITDA Growth Rate | 1.8 | |||||
3-Year EPS without NRI Growth Rate | 12 | |||||
3-Year Book Growth Rate | 2.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 19.59 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.99 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 93.89 | |||||
9-Day RSI | 93.92 | |||||
14-Day RSI | 91.07 | |||||
3-1 Month Momentum % | 2.43 | |||||
6-1 Month Momentum % | -3.8 | |||||
12-1 Month Momentum % | 5.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.57 | |||||
Quick Ratio | 2.45 | |||||
Cash Ratio | 1.63 | |||||
Days Inventory | 11.12 | |||||
Days Sales Outstanding | 56.07 | |||||
Days Payable | 20.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.42 | |||||
Dividend Payout Ratio | 0.17 | |||||
Forward Dividend Yield % | 1.42 | |||||
5-Year Yield-on-Cost % | 1.42 | |||||
Shareholder Yield % | 4.62 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 28.22 | |||||
Operating Margin % | 2.16 | |||||
Net Margin % | 2.32 | |||||
EBITDA Margin % | 6.97 | |||||
FCF Margin % | -2.43 | |||||
OCF Margin % | 3.31 | |||||
ROE % | 3.05 | |||||
ROA % | 2.16 | |||||
ROIC % | 2.37 | |||||
3-Year ROIIC % | -6.02 | |||||
ROC (Joel Greenblatt) % | 7.35 | |||||
ROCE % | 3.75 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.98 | |||||
Forward PE Ratio | 22.66 | |||||
PE Ratio without NRI | 18.12 | |||||
Shiller PE Ratio | 23.42 | |||||
PEG Ratio | 2.66 | |||||
PS Ratio | 0.42 | |||||
PB Ratio | 0.54 | |||||
Price-to-Tangible-Book | 0.69 | |||||
Price-to-Operating-Cash-Flow | 12.62 | |||||
EV-to-EBIT | 12.12 | |||||
EV-to-Forward-EBIT | 24.58 | |||||
EV-to-EBITDA | 5.56 | |||||
EV-to-Forward-EBITDA | 8.39 | |||||
EV-to-Revenue | 0.38 | |||||
EV-to-Forward-Revenue | 0.69 | |||||
EV-to-FCF | -16.58 | |||||
Price-to-GF-Value | 0.93 | |||||
Price-to-Projected-FCF | 0.73 | |||||
Price-to-Median-PS-Value | 0.63 | |||||
Price-to-Graham-Number | 0.78 | |||||
| Price-to-Net-Current-Asset-Value | 1.96 | |||||
| Price-to-Net-Cash | 11.24 | |||||
Earnings Yield (Greenblatt) % | 8.25 | |||||
FCF Yield % | -4.89 | |||||
Forward Rate of Return (Yacktman) % | 8.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rhoen Klinikum AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,726.13 | ||
| EPS (TTM) (€) | 0.6 | ||
| Beta | 0.1598 | ||
| 3-Year Sharpe Ratio | 0.05 | ||
| 3-Year Sortino Ratio | 0.09 | ||
| Volatility % | 13.19 | ||
| 14-Day RSI | 91.07 | ||
| 14-Day ATR (€) | 0.037117 | ||
| 20-Day SMA (€) | 13.695 | ||
| 12-1 Month Momentum % | 5.86 | ||
| 52-Week Range (€) | 11.4 - 14.3 | ||
| Shares Outstanding (Mil) | 66.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rhoen Klinikum AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rhoen Klinikum AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-06 | In 105 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 14 days | ||
| EUR 0.200000 Cash Dividend | 2026-05-28 | 12.55 (+0.00%) | ||
| General meeting for 2026 | 2026-05-27 10:00 | 12.55 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-08 | 12.80 (-0.78%) | ||
| Annual report for 2025 | 2026-03-26 | 12.70 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-06 | 11.65 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-07 | 11.80 (-0.84%) | ||
| EUR 0.100000 Cash Dividend | 2025-06-04 | 12.50 (-1.96%) | ||
| General meeting for 2025 | 2025-06-03 10:00 | 12.85 (-1.53%) |
Show
Entries
Rhoen Klinikum AG Frequently Asked Questions
What is Rhoen Klinikum AG(LTS:0NQH)'s stock price today?
The current price of LTS:0NQH is €12.70. The 52 week high of LTS:0NQH is €14.30 and 52 week low is €11.40.
When is next earnings date of Rhoen Klinikum AG(LTS:0NQH)?
The next earnings date of Rhoen Klinikum AG(LTS:0NQH) is 2026-08-07 Est..
Does Rhoen Klinikum AG(LTS:0NQH) pay dividends? If so, how much?
The Dividend Yield %  of Rhoen Klinikum AG(LTS:0NQH) is 1.42% (As of Today), Highest Dividend Payout Ratio of Rhoen Klinikum AG(LTS:0NQH) was 0.83. The lowest was 0.17. And the median was 0.38. The  Forward Dividend Yield % of Rhoen Klinikum AG(LTS:0NQH) is 1.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Rhoen Klinikum AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers